Answers are grounded in this paper and cite their sources.
Cohort study reveals increased metabolic syndrome prevalence during the menopausal transition alongside testosterone dominance, highlighting a potential pathway to higher cardiovascular disease risk.
As testosterone progressively dominates the hormonal milieu during the menopausal transition, the prevalence of MetS increases, independent of aging and other important covariates. This may be a pathway by which cardiovascular disease increases during menopause.
No takes yet. Share an insight, caveat, or question.
İmke Janssen (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: